chr11-67991615-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030930.4(UNC93B1):āc.1725C>Gā(p.Pro575Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00886 in 1,499,800 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0059 ( 6 hom., cov: 33)
Exomes š: 0.0092 ( 68 hom. )
Consequence
UNC93B1
NM_030930.4 synonymous
NM_030930.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.62
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-67991615-G-C is Benign according to our data. Variant chr11-67991615-G-C is described in ClinVar as [Benign]. Clinvar id is 782776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-67991615-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.62 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00591 (899/152182) while in subpopulation NFE AF= 0.00917 (623/67948). AF 95% confidence interval is 0.00857. There are 6 homozygotes in gnomad4. There are 420 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC93B1 | NM_030930.4 | c.1725C>G | p.Pro575Pro | synonymous_variant | 11/11 | ENST00000227471.7 | NP_112192.2 | |
UNC93B1 | XM_011545290.1 | c.1314C>G | p.Pro438Pro | synonymous_variant | 9/9 | XP_011543592.1 | ||
UNC93B1 | XM_011545291.3 | c.1170C>G | p.Pro390Pro | synonymous_variant | 8/8 | XP_011543593.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00592 AC: 900AN: 152074Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
900
AN:
152074
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00609 AC: 582AN: 95542Hom.: 3 AF XY: 0.00603 AC XY: 323AN XY: 53596
GnomAD3 exomes
AF:
AC:
582
AN:
95542
Hom.:
AF XY:
AC XY:
323
AN XY:
53596
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00919 AC: 12387AN: 1347618Hom.: 68 Cov.: 30 AF XY: 0.00892 AC XY: 5924AN XY: 664088
GnomAD4 exome
AF:
AC:
12387
AN:
1347618
Hom.:
Cov.:
30
AF XY:
AC XY:
5924
AN XY:
664088
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00591 AC: 899AN: 152182Hom.: 6 Cov.: 33 AF XY: 0.00565 AC XY: 420AN XY: 74396
GnomAD4 genome
AF:
AC:
899
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
420
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | UNC93B1: BP4, BP7, BS1, BS2 - |
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at